Ophiopogonin B induces apoptosis, mitotic catastrophe and autophagy in A549 cells.

Abstract:

:Ophiopogonin B (OP-B), a saponin compound isolated from Radix Ophiopogon japonicus, was verified to inhibit cell proliferation in numerous non-small cell lung cancer (NSCLC) cells in our previous study. However, the precise mechanisms of action have remained unclear. In the present study, we mainly investigated the effects of OP-B on adenocarcinoma A549 cells to further elaborate the underlying mechanisms of OP-B in different NSCLC cell lines. Detection by high content screening (HCS) and TUNEL assay verified that OP-B induced apoptosis in this cell line, while detection of Caspase-3, Bcl-2 and Bax showed that OP-B induced cell death was caspase and mitochondrial independent. Further experiments showed that OP-B induced cell cycle arrest in the S and G2/M phases by inhibiting the expression of Myt1 and phosphorylation of Histone H3 (Ser10), which resulted in mitotic catastrophe in the cells. Transmission electron microscopy (TEM) observation of cell micro-morphology combined with detection of Atgs by western blot analysis showed that OP-B induced autophagy in this cell line. Autophagy inhibition by the lysosome inhibitor CQ or Beclin1-siRNA knockdown both attenuated cell viability, demonstrated that autophagy also being the vital reason resulted in cell death. More importantly, the xenograft model using A549 cells provided further evidence of the inhibition of OP-B on tumor proliferation. Immunohistochemistry detection of LC3 and Tunel assay both verified that high dose of OP-B (75 mg/kg) induced autophagy and apoptosis in vivo, and western blot detection of p-Histone H3 (Ser10), Survivin and XIAP further indicated the molecular mechanism of OP-B in vivo. As our findings revealed, multiple types of cell death overlapped in OP-B treated A549 cells, it displayed multitarget characteristics of the compounds extracted from the Chinese herbal, which may be used as candidate anticancer medicine in clinic.

journal_name

Int J Oncol

authors

Chen M,Guo Y,Zhao R,Wang X,Jiang M,Fu H,Zhang X

doi

10.3892/ijo.2016.3514

subject

Has Abstract

pub_date

2016-07-01 00:00:00

pages

316-24

issue

1

eissn

1019-6439

issn

1791-2423

journal_volume

49

pub_type

杂志文章
  • Different dose regimens of the mouse monoclonal-antibody 17-1a for therapy of patients with metastatic colorectal-carcinoma.

    abstract::Seventy-one patients with metastatic colorectal carcinoma(CRC) were treated with varying doses of the mouse monoclonal antibody (MAb) 17-1A. One patient achieved a partial remission (PR) (1%) with a survival duration of 114+ months. Further 10 patients showed a minor response (MR) or stable disease > 3 months (SD) (14...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.7.5.1049

    authors: Ragnhammar P,Frodin J,Hjelm A,Fagerberg J,Wersall P,Lindemalm C,Nilsson B,Fox K,Magnusson I,Ewerth S,Thor K,Secher E,Mellstedt H

    更新日期:1995-11-01 00:00:00

  • Characterization of the tumor-promoting activity of m-chloroperoxybenzoic acid in SENCAR mouse skin and its inhibition by gallotannin, oligomeric proanthocyanidin, and their monomeric units.

    abstract::m-Chloroperoxybenzoic acid (CPBA),which induces ornithine decarboxylase activity as much as 12-O-tetradecanoylphorbol-13-acetate (TPA), was tested for its ability to induce DNA synthesis, hydroperoxide (HPx) production, and tumor promotion in mouse epidermis in vivo. After an early inhibition, CPBA stimulates DNA synt...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.8.1.197

    authors: Chen G,Perchellet E,Gao X,Johnson F,Davis A,Newell S,Hemingway R,Bottari V,Perchellet J

    更新日期:1996-01-01 00:00:00

  • Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma.

    abstract::The development of targeted molecular therapies has greatly benefited patients with lung adenocarcinomas. In contrast, these treatments have had little benefit in the management of lung squamous cell carcinoma (lung SCC). Therefore, new treatment options based on current genomic approaches are needed for lung SCC. Abe...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2016.3690

    authors: Kumamoto T,Seki N,Mataki H,Mizuno K,Kamikawaji K,Samukawa T,Koshizuka K,Goto Y,Inoue H

    更新日期:2016-11-01 00:00:00

  • Immunohistochemical pattern of cytokeratins and MMPs in human keratinocyte cell lines of different biological behaviour.

    abstract::We investigated three clonally related human keratinocyte cell lines of different biological behaviour, HaCaT (non-tumorigenic), A5 (benign, tumorigenic) and II-4RT (malignant, tumorigenic), with regard to the cell-associated localization of the major MMPs -1, -2, -3, -9, -10 and -11. These observations were correlate...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Bachmeier BE,Nerlich AG

    更新日期:2002-03-01 00:00:00

  • Differential regulation of cdk2 and cyclin D1 in irradiated human glioma cells.

    abstract::We have utilized a series of glioma cell lines to study the effects of ionizing radiation on the regulation of proteins that contribute to cell cycle progression. While no alterations of cyclin E or cdk4 were detected, a high percentage of glioma cell lines exhibited constitutive overexpression of cdk2 protein and abe...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.10.1.93

    authors: Pykett M,Azzam E,Little J

    更新日期:1997-01-01 00:00:00

  • Antitumor activity of human umbilical cord blood cells: A comparative analysis with peripheral blood and bone marrow cells.

    abstract::Although the hematopoietic reconstituting ability of human umbilical cord blood cells (UCBC) is well documented, their antitumor cytotoxic potential has not been well studied. Therefore, UCBC were compared to normal peripheral blood stem cells (PBSC) and bone marrow (BM) stem cell harvests for cytomorphology, antitumo...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.13.4.791

    authors: Joshi SS,Babushkina-Patz NN,Verbik DJ,Gross TG,Tarantolo SR,Kuszynski CA,Pirruccello SJ,Bishop MR,Kessinger A

    更新日期:1998-10-01 00:00:00

  • COL1A1: A potential therapeutic target for colorectal cancer expressing wild-type or mutant KRAS.

    abstract::Colorectal cancer (CRC) treatment primarily relies on chemotherapy along with surgery, radiotherapy and, more recently, targeted therapy at the late stages. However, chemotherapeutic drugs have high cytotoxicity, and the similarity between the effects of these drugs on cancerous and healthy cells limits their wider us...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2018.4536

    authors: Zhang Z,Fang C,Wang Y,Zhang J,Yu J,Zhang Y,Wang X,Zhong J

    更新日期:2018-11-01 00:00:00

  • Cetuximab-resistant oral squamous cell carcinoma cells become sensitive in anchorage-independent culture conditions through the activation of the EGFR/AKT pathway.

    abstract::We have previously shown that growth of the oral squamous cell carcinoma cell line SAS, is resistant to cetuximab in monolayer culture conditions, even though epidermal growth factor receptor (EGFR) was phosphorylated, but the growth of SAS aggregates was sensitive to cetuximab. In the present study, we demonstrate di...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2015.3215

    authors: Ohnishi Y,Yasui H,Kakudo K,Nozaki M

    更新日期:2015-12-01 00:00:00

  • Tie2-dependent deletion of α6 integrin subunit in mice reduces tumor growth and angiogenesis.

    abstract::The α6 integrin subunit (α6) has been implicated in cancer cell migration and in the progression of several malignancies, but its role in tumor angiogenesis is unclear. In mice, anti-α6 blocking antibodies reduce tumor angiogenesis, whereas Tie1-dependent α6 gene deletion enhances neovessel formation in melanoma and l...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2014.2631

    authors: Bouvard C,Segaoula Z,De Arcangelis A,Galy-Fauroux I,Mauge L,Fischer AM,Georges-Labouesse E,Helley D

    更新日期:2014-11-01 00:00:00

  • Different intracellular compartmentalization of TA and DeltaNp73 in non-small cell lung cancer.

    abstract::The p53 homologue p73 is overexpressed in many tumors, including lung cancer. We have evaluated the differential expression and subcellular localization of the functionally distinct apoptotic (TA) and anti-apoptotic (DeltaN) isoforms of p73 in non-small cell lung cancer (NSCLC), their possible association with p53 exp...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Di Vinci A,Sessa F,Casciano I,Banelli B,Franzi F,Brigati C,Allemanni G,Russo P,Dominioni L,Romani M

    更新日期:2009-02-01 00:00:00

  • Apoptotic responsiveness of PC-3 prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand: evidence for differential effects of Bcl-xL and Bcl-2 down-regulation.

    abstract::Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is cytotoxic to the majority of cancer cells while sparing most normal cells. However, different prostate carcinoma cell lines respond with different sensitivities to TRAIL, urging us to disclose the mechanisms that determine TRAIL sensitivity in prostate...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Sonnemann J,Gekeler V,Sagrauske A,Müller C,Hofmann HP,Beck JF

    更新日期:2004-10-01 00:00:00

  • Induction by hypoxia combined with low glucose or low bicarbonate and high posttranslational stability upon reoxygenation contribute to carbonic anhydrase IX expression in cancer cells.

    abstract::Hypoxia is an important factor of tumor microenvironment that significantly influences behaviour of tumor cells via activation of genes whose products are involved in adaptation to hypoxic stress, such as vascular endothelial growth factor (VEGF) and glucose transporter (GLUT-1). Carbonic anhydrase IX (CA IX) is one o...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Rafajová M,Zatovicová M,Kettmann R,Pastorek J,Pastoreková S

    更新日期:2004-04-01 00:00:00

  • P-glycoprotein-mediated multidrug resistance is modulated by pretreatment with chemosensitizers in HCT-8 carcinoma cells in vitro.

    abstract::The effects of pretreatment with the multidrug resistance (MDR) modulators verapamil (VPM), tamoxifen (TMX), cyclosporin A (CsA), and SDZ PSC833 (PSC) on drug sensitivity of the P-glycoprotein (Pgp) expressing human ileocecal carcinoma cell line HCT-8 is described. Following pretreatment of 2, 16 and 48 h with the ind...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.12.5.1137

    authors: Haberl I,Swatonek H,Schaufler K,Ulsperger E,Wenzl E,Theyer G,Hamilton G,Thalhammer T

    更新日期:1998-05-01 00:00:00

  • Trans-activating activity of the E6 proteins of the human papillomavirus (HPV) type-11 and -16 on the PE1E4 promoter of HPV-11 in C33A cells.

    abstract::We investigated trans-activating effects of the full-length E6 protein of HPV-16 (16E6) and the E6 protein of HPV-11 (11E6) on the PE1E4 promoter of HPV-11 in C33A cells which lack normal function of p53. 16E6 showed no significant activation of the reporter plasmid containing PE1E4 and the upstream sequence, includin...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.13.6.1253

    authors: Tomita Y,Asano Y,Shirasawa H

    更新日期:1998-12-01 00:00:00

  • DNA-hypomethylating agent, 5'-azacytidine, induces cyclooxygenase-2 expression via the PI3-kinase/Akt and extracellular signal-regulated kinase-1/2 pathways in human HT1080 fibrosarcoma cells.

    abstract::The cytosine analogue 5'-azacytidine (5'-aza) induces DNA hypomethylation by inhibiting DNA methyltransferase. In clinical trials, 5'-aza is widely used in epigenetic anticancer treatments. Accumulated evidence shows that cyclooxygenase-2 (COX-2) is overexpressed in various cancers, indicating that it may play a criti...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2015.3110

    authors: Yu SM,Kim SJ

    更新日期:2015-10-01 00:00:00

  • Mutation analysis of the putative tumor suppressor PTEN/MMAC1 in human ovarian cancer.

    abstract::A putative tumor suppressor, PTEN/MMAC1 gene was recently identified at 10q23 and was found to be frequently altered in several types of human tumors. To determine the possible role of this gene in human ovarian tumors, we screened 31 unselected primary epithelial ovarian cancers with matched normal tissues and 7 ovar...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.13.1.101

    authors: Yokomizo A,Tindall DJ,Hartmann L,Jenkins RB,Smith DI,Liu W

    更新日期:1998-07-01 00:00:00

  • Histone deacetylase inhibitors, valproic acid and trichostatin-A induce apoptosis and affect acetylation status of p53 in ERG-positive prostate cancer cells.

    abstract::An ETS family member, ETS Related Gene (ERG) is involved in the Ewing family of tumors as well as leukemias. Rearrangement of the ERG gene with the TMPRSS2 gene has been identified in the majority of prostate cancer patients. Additionally, overexpression of ERG is associated with unfavorable prognosis in prostate canc...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2011.1014

    authors: Fortson WS,Kayarthodi S,Fujimura Y,Xu H,Matthews R,Grizzle WE,Rao VN,Bhat GK,Reddy ES

    更新日期:2011-07-01 00:00:00

  • CEOP-B/VIMB vs. promace-CytaBOM in the treatment of intermediate or high grade non-Hodgkin's lymphoma: A randomised multicenter study of Southern Italy Cooperative Group.

    abstract::From January 1992 to December 1995, 129 patients with previously untreated non-Hodgkin's lymphoma were randomised in a phase III multicenter trial to receive CEOP-B/VIMB or ProMACE-CytaBOM. Eligibility criteria included intermediate or high grade lymphoma (follicular large cell, diffuse small cleaved-cell, diffuse mix...

    journal_title:International journal of oncology

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.3892/ijo.16.1.149

    authors: Lorusso V,Palmieri G,Bianco AR,Abate G,Catalano G,De Vita F,Dammacco F,Lauta VM,Lucarelli G,Polimeno G,Mantovani G,D'Aprile M,Marzullo F,De Lena M

    更新日期:2000-01-01 00:00:00

  • Immunotherapy of breast cancer by single delivery with rAAV2-mediated interleukin-15 expression.

    abstract::Recombinant adenovirus-associated vector serotype 2 (rAAV2) is one of the most promising gene transfer vectors due to its advantage of causing non-pathogenic infection, low immunogenicity, and long-term gene expression in human clinical trials. Human interleukin 15 (hIL15) has been implicated in modulation of antitumo...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Yu YL,Wei CW,Chen YL,Chen MH,Yiang GT

    更新日期:2010-02-01 00:00:00

  • Differential expression profiles of sense and antisense transcripts between HCV-associated hepatocellular carcinoma and corresponding non-cancerous liver tissue.

    abstract::Recent studies have demonstrated that natural antisense transcripts, which are complementary sequences to messenger RNA, have important cellular functions such as the stabilization and silencing of mRNA. However, the possible contribution of antisense transcripts in hepatocellular c...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2012.1382

    authors: Nagai K,Kohno K,Chiba M,Pak S,Murata S,Fukunaga K,Kobayashi A,Yasue H,Ohkohchi N

    更新日期:2012-06-01 00:00:00

  • Overexpression of α1,6-fucosyltransferase in hepatoma enhances expression of Golgi phosphoprotein 2 in a fucosylation-independent manner.

    abstract::Golgi phosphoprotein 2 (GP73) is a type II Golgi protein, which was found on examination of the fucosylated proteome as a potential tumor marker for hepatocellular carcinoma (HCC). The serum levels of both total and fucosylated GP73 were increased in the sera of patients with HCC. Fucosylation is one of the most impor...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2011.1005

    authors: Kawamoto S,Moriwaki K,Nakagawa T,Terao M,Shinzaki S,Yamane-Ohnuki N,Satoh M,Mehta AS,Block TM,Miyoshi E

    更新日期:2011-07-01 00:00:00

  • A critical perspective in cancer research (Review).

    abstract::Over the past few decades, there has been a tremendous increase in cancer biology data and treatment. Cancer research has opened exciting new areas of cellular and molecular biology. Month by month, new genes which regulate the carcinogenesis process are being discovered. The result is an incredible knowledge of cance...

    journal_title:International journal of oncology

    pub_type: 杂志文章,评审

    doi:10.3892/ijo.15.6.1213

    authors: Kanduc D,Bannasch P,Farber E

    更新日期:1999-12-01 00:00:00

  • Abnormal expression of Forkhead Box J2 (FOXJ2) suppresses migration and invasion in extrahepatic cholangiocarcinoma and is associated with prognosis.

    abstract::Extrahepatic cholangiocarcinoma (CC) is an aggressive malignancy with dismal prognosis and characterized by early invasion, metastasis and postoperative recurrence. Therefore, understanding the main molecular mechanisms of this malignancy is the key for the development of novel and effective therapeutic strategies for...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2015.2957

    authors: Qiang Y,Wang F,Yan S,Zhang H,Zhu L,Chen Z,Tu F,Wang D,Wang G,Wang W,Chen Z

    更新日期:2015-01-01 00:00:00

  • MicroRNA-24 upregulation inhibits proliferation, metastasis and induces apoptosis in bladder cancer cells by targeting CARMA3.

    abstract::Increasing evidence has confirmed that dysregulation of microRNAs (miRNAs) can contribute to the progression and metastasis of human tumors. Previous studied have shown dysregulation of miR-24 in a variety of tumors. However, the roles of miR-24 in human bladder cancer have not been well clarified. Therefore, we inves...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2015.3117

    authors: Zhang S,Zhang C,Liu W,Zheng W,Zhang Y,Wang S,Huang D,Liu X,Bai Z

    更新日期:2015-10-01 00:00:00

  • Retinoid receptor mRNA expression profiles in human bladder cancer specimens.

    abstract::Retinoids, which include vitamin A (retinol) and its derivatives, have previously been investigated as potential chemopreventive and chemotherapeutic agents in bladder cancer. We examined mRNA expression of the retinoid receptors RARalpha, RARbeta2, RARgamma and RXRalpha, as well as two putative RARbeta2 target genes,...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Boorjian S,Scherr DS,Mongan NP,Zhuang Y,Nanus DM,Gudas LJ

    更新日期:2005-04-01 00:00:00

  • Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.

    abstract::This study examines the role of LEF1, a component of the Wnt signaling pathway, in human breast and murine mammary carcinoma and its relationship to ErbB2 (her-2/neu) expression. Mammary tissue and tumors from 5 different Wnt pathway-activated transgenic mouse strains and 5 different ErbB2 pathway-activated transgenic...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Nguyen A,Rosner A,Milovanovic T,Hope C,Planutis K,Saha B,Chaiwun B,Lin F,Imam SA,Marsh JL,Holcombe RF

    更新日期:2005-10-01 00:00:00

  • Aberrant expression of p53 and retinoblastoma gene products in human esophageal squamous cell carcinoma.

    abstract::The aberrant expression of p53 and RB proteins was investigated by immunohistochemistry in 73 patients with esophageal SCC, who underwent esophageal resection. Fresh tumor tissues from 21 patients were also tested for p53 mutations in exons 4 through 9 by direct sequencing. Positive nuclear staining with p53 antibody ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.11.5.1109

    authors: Ishikawa T,Furihata M,Ohtsuki Y,Ono H,Inoue A,Ogoshi S

    更新日期:1997-11-01 00:00:00

  • The anticancer agent pb-100 concentrates in the nucleus and nucleoli of human glioblastoma cells but does not enter normal astrocytes.

    abstract::Selectivity of the anticancer agent PB-100 for malignant cells, already demonstrated using cell growth and viability evaluation, is now confirmed by microscopic observations. PB-100 is easily detected inside cells by its yellow color under visible light and by its blue fluorescence; it may be measured in isolated nucl...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.7.1.81

    authors: Beljanski M,Crochet S

    更新日期:1995-07-01 00:00:00

  • Genetic predisposition and specific chromosomal defects associated with Sinclair swine malignant melanomas.

    abstract::Cytogenetic abnormalities are the hallmarks of most cancers and cutaneous melanomas are no exception. The purpose of this study was to determine whether nonrandom chromosomal abnormalities are associated with development and spontaneous regression of congenital cutaneous melanoma in Sinclair miniature swine. Careful a...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.11.1.53

    authors: Pathak S,Amoss M

    更新日期:1997-07-01 00:00:00

  • Platelet adherence to cancer cells promotes escape from innate immune surveillance in cancer metastasis.

    abstract::The impacts of post‑operative abdominal infectious complications increase hematogenous distant metastasis and result in poor long‑term survival after curative resection. Even if curative resection can be performed, the presence of circulating tumor cells is affected. The liver, the most common site of metastases, is a...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2020.5102

    authors: Okazaki M,Yamaguchi T,Tajima H,Fushida S,Ohta T

    更新日期:2020-10-01 00:00:00